Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jun;26(3):842-851.
doi: 10.1111/jep.13261. Epub 2019 Aug 21.

Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials

Nourin Ali Sherif  1   2 , Mostafa Ebraheem Morra  3 , Le Van Thanh  2   4 , Ghadeer Gamal Elsayed  2   5 , Aya Hesham Elkady  2   6 , Abdelrahman Elshafay  2   3 , Nguyen Dang Kien  7 , Ahmed Al-Habbaa  8 , Le Huu Nhat Minh  2   4 , Mai Nhu Y  2   9 , Thai Le Ba Nghia  2   9 , Abdelrhman Tarek Mohammed  2   3 , Peter Samuel Eid  2   10 , Tarek Turk  11 , Kenji Hirayama  12 , Nguyen Tien Huy  13   14
Affiliations
Meta-Analysis

Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials

Nourin Ali Sherif et al. J Eval Clin Pract. 2020 Jun.

Abstract

Aim: Diuretics are a cornerstone in treatment of heart failure (HF). Torasemide is a loop diuretic with a potential advantage over other diuretics. We aim to meta-analyse and compare the effect of torasemide with furosemide in HF patients.

Methods: A comprehensive literature search using 12 databases including PubMed, Scopus, and Web of Science was performed. All randomized controlled trials (RCTs) comparing furosemide and torasemide in HF patients were included and meta-analysed. We assessed the risk of bias using Cochrane Collaboration's tool. The protocol was registered in PROSPERO (CRD42016046112).

Results: Eighteen RCTs with 1598 patients were included. There was a significant difference between torasemide 20 mg and furosemide 40 mg in increasing the urine volume (standard difference of the mean (SDM) [95% confidence interval] = -0.78 [-1.52 to -0.053], P = .036). Torasemide 10 mg and 10 to 20 mg have a significant effect on potassium excretion in comparison with furosemide 25 to 40 mg (P = .018 and .023, respectively). In general, torasemide and furosemide have no significant difference in mortality, edema improvement, weight loss, heart rate, and reducing systolic/diastolic blood pressure. However, oral torasemide has a significant lower hospital stay P < .001 and superior effect in improving ejection fraction P = .029.

Conclusion: Although not all results are statistically significant, torasemide has potential advantages on multiple aspects of HF management when compared with furosemide. More studies are needed to clarify these effects.

Keywords: efficacy; furosemide; heart failure; torasemide.

PubMed Disclaimer

References

REFERENCES

    1. Christ M, Störk S, Dörr M, et al. Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System. Eur J Heart Fail. 2016;18(8):1009-1018.
    1. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J Engl. 2004;25(18):1614-1619.
    1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200.
    1. Rich MW. Congestive heart failure in older adults: epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45(8):968-974.
    1. Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev. 2012;2:CD003838.